Verona Submits New Drug Application for Ensifentrine for COPDÂ
If approved, it is expected to be the first novel mechanism available for the treatment of COPD in over 10 years.
If approved, it is expected to be the first novel mechanism available for the treatment of COPD in over 10 years.